Holen Sie sich die Stockscreener-App
72.92
0.80%
0.58
Schlusskurs vom Vortag:
$72.34
Offen:
$72.58
24-Stunden-Volumen:
550.42K
Relative Volume:
0.58
Marktkapitalisierung:
$12.62B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$379.00M
KGV:
33.76
EPS:
2.16
Netto-Cashflow:
$385.00M
1W Leistung:
-1.03%
1M Leistung:
-0.88%
6M Leistung:
-1.00%
1J Leistung:
+34.71%
1-Tages-Spanne:
$72.11
$73.30
1-Wochen-Bereich:
$71.98
$74.66
52-Wochen-Spanne:
$54.26
$85.92
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
72.92 | 12.75B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
|
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Lobbying Update: $60,000 of SOLVENTUM lobbying was just disclosed - Nasdaq
What analysts say about Solventum Corporation stockExtraordinary market timing - jammulinksnews.com
Solventum: Appealing Again (NYSE:SOLV) - Seeking Alpha
Is Solventum Corporation a good long term investmentExceptional growth trajectory - jammulinksnews.com
What drives Solventum Corporation stock priceOutstanding trading profits - jammulinksnews.com
Steris, Solventum upgraded, RxSight downgraded in Morgan Stanley's MedTech review - MSN
Solventum Corporation Stock Analysis and ForecastHigh-performance investment picks - PrintWeekIndia
As more Minnesota companies rethink remote work, Solventum and others hold the line on flexibility - Star Tribune
Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025 - The Malaysian Reserve
Solventum To Report Second Quarter Fiscal 2025 Earnings On August 7, 2025 - Barchart.com
Steris, Solventum stocks upgraded at Morgan Stanley (STE:NYSE) - Seeking Alpha
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential By Investing.com - Investing.com South Africa
Morgan Stanley upgrades Solventum stock rating to Overweight on margin potential - Investing.com India
Morgan Stanley Upgrades Solventum to Overweight From Equalweight, Adjusts PT to $103 From $80 - MarketScreener
Thermo Fisher Wins EU Approval for Acquisition of Solventum's Filtration Business - MarketScreener
European Commission OKs Thermo Fisher's Purchase of Solventum's Purification, Filtration Arm - MarketScreener
Solventum Launches Two Dental Innovations in Thailand - MSN
Tandem Diabetes, Solventum, LeMaitre, UFP Technologies, and Artivion Stocks Trade Down, What You Need To Know - MSN
Markets | American Financial Group, Inc. - FinancialContent
Solventum Corp. Stock Falls Tuesday, Underperforms Market - 富途牛牛
Solventum Corp (SOLV) Upgraded to a ‘Buy’ at Argus Research - Insider Monkey
Solventum (NYSE:SOLV) Has A Somewhat Strained Balance Sheet - simplywall.st
Is the Options Market Predicting a Spike in Solventum Stock? - MSN
Discussing the removal of dissolved gases from water with Solventum - watertechonline.com
Solventum Amends Thermo Fisher Deal, Retains Water Filtration Business - MSN
How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks? - MSN
Solventum (NYSE:SOLV) Stock Rating Upgraded by Argus - MarketBeat
Solventum Shows Market Leadership With Jump To 83 RS Rating - Investor's Business Daily
Solventum's Strategic Shift Sparks Analyst Optimism Amid Diverging Price Targets - AInvest
Solventum Shares Rise After Argus Research Upgrade - MarketScreener
Argus Research Upgrades Solventum to Buy From Hold, $90 Price Target - MarketScreener
5 Must-Read Analyst Questions From Solventum’s Q1 Earnings Call - Yahoo Finance
How Is Solventum's Stock Performance Compared To Other Health Care Equipment Stocks? - Barchart.com
Bryan C. Hanson - Walgreens Boots Alliance
Solventum Named a Best Company to Work for by U.S. News & World Report - GuruFocus
How Did Solventum Corporation's (NYSE:SOLV) 12% ROE Fare Against The Industry? - Yahoo Finance
With 68% ownership, Solventum Corporation (NYSE:SOLV) boasts of strong institutional backing - simplywall.st
SOLV Q1 Earnings Call: Margin Headwinds Offset by Volume Growth and Product Momentum - Yahoo Finance
Solventum Launches Preassembled, See-through VH2O2 Test Pack for Low-temp Medical Instrument Sterilization - PR Newswire
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):